Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Yadav, Bhagwan ^a   Pemovska, Tea ^a   Szwajda, Agnieszka ^a   Kulesskiy, Evgeny ^a   Kontro, Mika ^b   Karjalainen, Riikka ^a   Majumder, Muntasir Mamun ^a   Malani, Disha ^a   Murumägi, Astrid ^a   Knowles, Jonathan ^a   Porkka, Kimmo ^b   Heckman, Caroline ^a   Kallioniemi, Olli ^a   Wennerberg, Krister ^a   Aittokallio, Tero ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ALGORITHM; CASE CONTROL STUDY; COMPARATIVE STUDY; DRUG EFFECTS; DRUG RESISTANCE; HUMAN; LEUKEMIA, MYELOID, ACUTE; NEOPLASM RECURRENCE, LOCAL; PERSONALIZED MEDICINE; THEORETICAL MODEL; TUMOR CELL CULTURE;

ALGORITHMS; ANTINEOPLASTIC AGENTS; CASE-CONTROL STUDIES; DRUG RESISTANCE, NEOPLASM; HUMANS; INDIVIDUALIZED MEDICINE; LEUKEMIA, MYELOID, ACUTE; MODELS, THEORETICAL; NEOPLASM RECURRENCE, LOCAL; TUMOR CELLS, CULTURED;

EID: 84902095891     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep05193     Document Type: Article

References (22)

1. Heiser, L. M. et al. Subtype and pathway specific responses to anticancercompounds in breast cancer. Proc. Natl. Acad. Sci. 109, 2724-9 (2012).
2. Garnett, M. J. et al. Systematic identification of genomic markers of drugsensitivity in cancer cells. Nature 483, 570-5 (2012).
3. Barretina, J. et al. The Cancer Cell Line Encyclopedia enables predictive modellingof anticancer drug sensitivity. Nature 483, 603-7 (2012).
4. Basu, A. et al. An interactive resource to identify cancer genetic and lineagedependencies targeted by small molecules. Cell 154, 1151-61 (2013).
5. Tyner, J. W. et al. Kinase pathway dependence in primary human leukemiasdetermined by rapid inhibitor screening. Cancer Res. 73, 285-296 (2013).
6. Pemovska, T. et al. Individualized systems medicine strategy to tailor treatmentsfor patients with chemorefractory acute myeloid leukemia. Cancer Discov. 3,1416-29 (2013).
7. Monks, A. et al. Feasibility of a high-flux anticancer drug screen using adiverse panel of cultured human tumor cell lines. J. Natl. Cancer Inst. 83,757-766 (1991).
8. Kuo, W. L. et al. Asystems analysis of the chemosensitivity of breast cancer cells tothe polyamine analogue PG-11047. BMC Med. 7, 77 (2009).
9. Fallahi-Sichani, M. et al.Metrics other than potency reveal systematic variation inresponses to cancer drugs. Nat. Chem. Biol. 9, 708-14 (2013).
10. Eghtedar, A. et al. Phase 2 study of the JAK kinase inhibitor ruxolitinib in patientswith refractory leukemias, including postmyeloproliferative neoplasm acutemyeloid leukemia. Blood 119, 4614-8 (2012).
11. Davis, M. I. et al. Comprehensive analysis of kinase inhibitor selectivity. Nat.Biotechnol. 29, 1046-51 (2011).
12. Welch, J. S. et al. The origin and evolution of mutations in acute myeloid leukemia.Cell 150, 264-278 (2012).
13. Haibe-Kains, B. et al. Inconsistency in large pharmacogenomic studies. Nature504, 389-93 (2013).
14. Tang, J. et al. Target inhibition networks: predicting selective combinations ofdruggable targets to block cancer survival pathways. PLOS Comput. Biol. 9,e1003226 (2013).
15. D'Agostino, R. B. Transformation to normality of the null distribution of G1.Biometrika 57, 679-681 (1970).
16. Hanley, J. A. & McNeil, B. J. The meaning and use of the area under a receiveroperating Characteristic (ROC) curve. Radiology 143, 29-36 (1982).
17. DeLong, E. R.,DeLong, D. M. & Clarke-Pearson, D. L. Comparing the areas undertwo or more correlated receiver operating characteristic curves: a nonparametricapproach. Biometrics 44, 837-845 (1988).
18. Shannon, P. et al. Cytoscape: a software environment for integrated models ofbiomolecular interaction networks. Genome Res. 13, 2498-504 (2003).
19. Ward, J. H. Hierarchical grouping to optimize an objective function. J. Am. Stat.Assoc. 58, 236-244 (1963).
20. Langfelder, P., Zhang, B. & Horvath, S. Defining clusters from a hierarchicalcluster tree: the Dynamic Tree Cut package for R. Bioinformatics 24, 719-20(2008).
21. Hubert, L. & Arabie, P. Comparing partitions. J. Classif. 2, 193-218 (1985).
22. Fowlkes, E. B. & Mallows, C. L. A method for comparing two hierarchicalclusterings. J. Am. Stat. Assoc. 78, 553 (1983).